Outset Medical, Inc.
OM- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001484612
In the last 90 days, Outset Medical, Inc. insiders filed 1 open-market purchase and 2 sales; 93 institutions reported holding it in 13F filings for Q2 2026, worth $59.9M in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 17, 2026
- $59.6M
- Insider buysLast 90 days, $870.3K in total
- 1
- Insider sellsLast 90 days, $29.0K in total
- 2
- 13F holdersQ2 2026, −4 vs. previous quarter
- 93
- 13F valueReported value at the end of Q2 2026
- $59.9M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $119.5M
- +5.1% year over year
- Net income, FY2025
- -$81.7M
- No comparable prior period
- Free cash flow, FY2025
- -$47.1M
- No comparable prior period
- Revenue, Q3 FY2026
- $33.6M
- +14.2% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net loss for FY2025: $81.7M (68.3% of revenue).
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 812.8K
- Shares sold short
- Change
- −119.8K
- −12.9% vs. previous
- Days to cover
- 8.61
- At average daily volume
Superinvestors holding OM, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding OM at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Outset Medical, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2026 (view filing)7:31 PM ET | Nov 16 | 1 day | Gaeta ReneeChief Financial Officer | SSale | −4.50K | $3.67 | −$16.5K | −2.5%176.3K after | |
| Nov 17, 2026 (view filing)7:28 PM ET | Nov 16 | 1 day | Trigg LeslieChair and CEO | SSale | −3.40K | $3.67 | −$12.5K | −1.7%191.2K after | |
| Oct 5, 2026 (view filing)7:24 PM ET | Oct 1-2 | 4 days | Leonard Braden Michael10% Owner | PPurchase | +244.9K | $3.55 | +$870.3K | +9.7%2.76M after | 2 lots |
| Aug 18, 2026 (view filing)7:45 PM ET | Aug 17 | 1 day | Trigg LeslieChair and CEO | SSale | −3.44K | $4.39 | −$15.1K | −1.7%194.6K after | |
| Aug 18, 2026 (view filing)6:51 PM ET | Aug 17 | 1 day | Brottem John L.General Counsel | SSale | −2.63K | $4.39 | −$11.6K | −2.9%87.5K after | |
| Aug 18, 2026 (view filing)6:46 PM ET | Aug 17 | 1 day | Gaeta ReneeChief Financial Officer | SSale | −4.54K | $4.39 | −$19.9K | −2.5%180.8K after | |
| Jun 5, 2026 (view filing) | Jun 3 | 2 days | Gaeta ReneeChief Financial Officer | SSale | −17.7K | $4.94 | −$87.3K | −13.4%113.8K after | |
| May 19, 2026 (view filing) | May 15 | 4 days | Trigg LeslieChair and CEO | SSale | −3.44K | $3.70 | −$12.7K | −3.4%98.9K after | |
| May 19, 2026 (view filing) | May 15 | 4 days | Nash MarcEVP Operations R&D & Service | SSale | −1.58K | $3.70 | −$5.85K | −4.0%38.4K after | |
| May 19, 2026 (view filing) | May 15 | 4 days | Brottem John L.General Counsel | SSale | −2.64K | $3.70 | −$9.76K | −8.0%30.3K after |
Top 10 13F holders, Q2 2026
See all 93 holdersThe largest institutional positions in Outset Medical, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 2,742,887 | $11.8M | 0.00% | +1,2140.0% | Added |
| BML Capital Management, LLC | 2,519,701 | $10.9M | 6.22% | +617,500+32.5% | Added |
| AQR Capital Management LLC | 998,961 | $4.32M | 0.00% | +190,676+23.6% | Added |
| Perceptive Advisors LLC | 833,333 | $3.60M | 0.06% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 780,134 | $3.37M | 0.00% | +16,312+2.1% | Added |
| Bank of America Corp | 665,847 | $2.88M | 0.00% | −283,550−29.9% | Reduced |
| PFM Health Sciences, LP | 582,122 | $2.51M | 0.22% | −12,508−2.1% | Reduced |
| Ensign Peak Advisors, Inc | 434,341 | $1.88M | 0.00% | −92,244−17.5% | Reduced |
| BlackRock, Inc. | 418,211 | $1.81M | 0.00% | −845,008−66.9% | Reduced |
| Assenagon Asset Management S.A. | 339,438 | $1.47M | 0.00% | −164,655−32.7% | Reduced |
Holders of 5% or more of OM
See all 4 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Outset Medical, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BML Investment Partners, L.P. | 13G/A | 14.70%2.76M shares | +1.10 ppfrom 13.60% | Jan 14, 20265 filings | Oct 6, 2026 | SEC |
| FMR LLC | 13G/A | 14.50%2.60M shares | +7.50 ppfrom 7.00% | Feb 8, 20217 filings | Apr 7, 2025 | SEC |
| Perceptive Advisors LLC | 13G | 9.50%5.63M shares | – | Feb 16, 20213 filings | Feb 28, 2025 | SEC |
| Perceptive Advisors LLC | 13G/A | 6.70%1.21M shares | – | May 15, 20251 filing | May 15, 2025 | SEC |